RT @jonathancgrant: @KarimKhan_IMHA @YouTube Just watched this great summary of the challenges associated with the ‘17 years … what’s the q…
@KarimKhan_IMHA @YouTube Just watched this great summary of the challenges associated with the ‘17 years … what’s the question’ issue when looking at time lags in biomedical research. On the application of the proposed model we did try to apply that to Cov
What can be done when their is a 'will' from all sides to address traditional barriers to knowledge mobilisation. @PhysioKTBroker nice example of a best case scenario below 👇 #KnowledgeTranslation #MindTheGap
RT @jonathancgrant: @KarimKhan_IMHA The issue with the 17 yrs is a) it is an average and the interesting issue is the distribution and b) t…
@KarimKhan_IMHA The issue with the 17 yrs is a) it is an average and the interesting issue is the distribution and b) the data as you note is old - the challenge is it is very hard to measure. We did this related paper on COVID that may be of interest.
RT @hergbrunel: From a research angle pleasing to see that in posing the question about having seen COVID-19 vaccines developed at a speed…
From a research angle pleasing to see that in posing the question about having seen COVID-19 vaccines developed at a speed "inconceivable pre-pandemic", then "What else is possible that was previously impossible?" they draw on: https://t.co/2zbolC5D4S
RT @jonathancgrant: Given today’s news worth re-tweeting this paper published in June. https://t.co/5TGzSTuQCi
RT @jonathancgrant: Given today’s news worth re-tweeting this paper published in June. https://t.co/5TGzSTuQCi
Given today’s news worth re-tweeting this paper published in June. https://t.co/5TGzSTuQCi
RT @hergbrunel: Yes, a COVID-19 vaccine, as we suggested in June, could be ready in months not years : @hergbrunel @jonathancgrant @drst…
RT @hergbrunel: Yes, a COVID-19 vaccine, as we suggested in June, could be ready in months not years : @hergbrunel @jonathancgrant @drst…
RT @hergbrunel: Yes, a COVID-19 vaccine, as we suggested in June, could be ready in months not years : @hergbrunel @jonathancgrant @drst…
Yes, a COVID-19 vaccine, as we suggested in June, could be ready in months not years : @hergbrunel @jonathancgrant @drstevenwooding based on our @The_MRC funded paper also in @HarpsJournal : https://t.co/2zbolC5D4S
RT @hergbrunel: 2/2 Our paper discussing how to combine speed, safety & efficacy in vaccine development is cited in The Conversation piece…
RT @hergbrunel: 2/2 Our paper discussing how to combine speed, safety & efficacy in vaccine development is cited in The Conversation piece…
2/2 Our paper discussing how to combine speed, safety & efficacy in vaccine development is cited in The Conversation piece @hergbrunel @jonathancgrant @drstevenwooding based on our @The_MRC funded timelags paper also in @HarpsJournal : https://t.
RT @jonathancgrant: Great to see our COVID paper in time lags cited in this piece. https://t.co/5TGzSTuQCi
Great to see our COVID paper in time lags cited in this piece. https://t.co/5TGzSTuQCi
No nos estamos saltando etapas en el camino, paso al coraje: entendamos y no temamos! https://t.co/fqxk6FlmVT
RT @hergbrunel: COVID-19 vaccine in 17 months not 17 years? New analysis & future lessons by @hergbrunel @jonathancgrant @drstevenwooding…
RT @drstevenwooding: 17 years to 17 months? What can we learn from SARS-CoV-2 vaccine development and might it change the rest of medical r…
RT @drstevenwooding: 17 years to 17 months? What can we learn from SARS-CoV-2 vaccine development and might it change the rest of medical r…
RT @drstevenwooding: 17 years to 17 months? What can we learn from SARS-CoV-2 vaccine development and might it change the rest of medical r…
RT @drstevenwooding: 17 years to 17 months? What can we learn from SARS-CoV-2 vaccine development and might it change the rest of medical r…
17 years to 17 months? What can we learn from SARS-CoV-2 vaccine development and might it change the rest of medical research? Ideas in our new paper https://t.co/KppV6gqcs5 @hergbrunel, @jonathancgrant, @RANDEurope
RT @BennettInst: Affiliated Researcher Steven Wooding asks 'What can we learn from the accelerated development of SARS-Cov-2 vaccines, and…
RT @drstevenwooding: What can we learn from the accelerated development of SARS-Cov-2 vaccines, and might it be applied to other areas of m…
RT @BennettInst: Affiliated Researcher Steven Wooding asks 'What can we learn from the accelerated development of SARS-Cov-2 vaccines, and…
Affiliated Researcher Steven Wooding asks 'What can we learn from the accelerated development of SARS-Cov-2 vaccines, and might it be applied to other areas of medical research?' Ideas in a new paper https://t.co/Sqc5tdbqdx with @hergbrunel, @jonathancgran
RT @drstevenwooding: What can we learn from the accelerated development of SARS-Cov-2 vaccines, and might it be applied to other areas of m…
What can we learn from the accelerated development of SARS-Cov-2 vaccines, and might it be applied to other areas of medical research? Ideas in our new paper https://t.co/KppV6gqcs5 @hergbrunel, @jonathancgrant, @RANDEurope
RT @hergbrunel: COVID-19 vaccine in 17 months not 17 years? New analysis & future lessons by @hergbrunel @jonathancgrant @drstevenwooding…
From COVID-19 research to vaccine application: why might it take 17 months not 17 years? https://t.co/akNBZF0Ckc Possible to accelerate research but there will be greater (but proportionate) risks to safety & financial trade-offs.
RT @RANDEurope: There is an enormous global effort to develop a vaccine for #COVID19 at an expedited pace. Could these efforts provide less…
RT @hergbrunel: COVID-19 vaccine in 17 months not 17 years? New analysis & future lessons by @hergbrunel @jonathancgrant @drstevenwooding…
From COVID-19 research to vaccine application: why might it take 17 months not 17 years and what are the wider lessons? https://t.co/0T7yyejcfL
RT @hergbrunel: COVID-19 vaccine in 17 months not 17 years? New analysis & future lessons by @hergbrunel @jonathancgrant @drstevenwooding…
RT @NicoleVotruba: Covid19 #researchtranslation bench to bedside. Will it take 17 years again? Answers in this paper!
Covid19 #researchtranslation bench to bedside. Will it take 17 years again? Answers in this paper!
RT @RANDEurope: There is an enormous global effort to develop a vaccine for #COVID19 at an expedited pace. Could these efforts provide less…
Sorry - thought I had added the link ... here it is: https://t.co/5TGzSTuQCi
There is an enormous global effort to develop a vaccine for #COVID19 at an expedited pace. Could these efforts provide lessons to help accelerate medical research when the crisis eases? RAND expert Jon Sussex et al explore in a new @BioMedCentral article.
RT @hergbrunel: COVID-19 vaccine in 17 months not 17 years? New analysis & future lessons by @hergbrunel @jonathancgrant @drstevenwooding…
RT @hergbrunel: COVID-19 vaccine in 17 months not 17 years? New analysis & future lessons by @hergbrunel @jonathancgrant @drstevenwooding…
RT @hergbrunel: COVID-19 vaccine in 17 months not 17 years? New analysis & future lessons by @hergbrunel @jonathancgrant @drstevenwooding…
RT @hergbrunel: COVID-19 vaccine in 17 months not 17 years? New analysis & future lessons by @hergbrunel @jonathancgrant @drstevenwooding…
Promising
COVID-19 vaccine in 17 months not 17 years? New analysis & future lessons by @hergbrunel @jonathancgrant @drstevenwooding & Jon Sussex informed by earlier @The_MRC funded paper also in @HarpsJournal : https://t.co/zZErIEuwoa